Tue Sep 24 04:18:58 UTC 2024: ## Synthetic Biologics Shares Rise Slightly on Monday

**New York, NY – September 24, 2024** – Synthetic Biologics, Inc. (NYSEAMERICAN:SYN) saw a modest 1% increase in its share price on Monday, closing at $1.02. The company, which focuses on developing treatments for unmet medical needs, traded a total of 57,700 shares, significantly lower than the average daily volume of 197,338 shares.

Synthetic Biologics’ lead product candidates include SYN-004, designed to prevent microbiome damage and other complications related to antibiotic use, and SYN-020, a treatment for both localized GI and systemic diseases. The company currently has a market cap of $16.16 million and a price-to-earnings ratio of -0.84.

While the stock’s performance on Monday was positive, it remains to be seen if this upward trend will continue. Investors are encouraged to keep an eye on the company’s future developments and clinical trial results for further insight into its potential.

Read More